[go: up one dir, main page]

IL179545A0 - Viral and viral associated mirnas and uses thereof - Google Patents

Viral and viral associated mirnas and uses thereof

Info

Publication number
IL179545A0
IL179545A0 IL179545A IL17954506A IL179545A0 IL 179545 A0 IL179545 A0 IL 179545A0 IL 179545 A IL179545 A IL 179545A IL 17954506 A IL17954506 A IL 17954506A IL 179545 A0 IL179545 A0 IL 179545A0
Authority
IL
Israel
Prior art keywords
viral
associated mirnas
mirnas
viral associated
Prior art date
Application number
IL179545A
Other versions
IL179545A (en
Original Assignee
Yael Karov
Rosetta Genomics Ltd
Itzhak Bentwich
Amir Avniel
Ranit Aharonov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/709,739 external-priority patent/US7777022B2/en
Application filed by Yael Karov, Rosetta Genomics Ltd, Itzhak Bentwich, Amir Avniel, Ranit Aharonov filed Critical Yael Karov
Publication of IL179545A0 publication Critical patent/IL179545A0/en
Publication of IL179545A publication Critical patent/IL179545A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16221—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IL179545A 2004-05-26 2006-11-23 Viral and viral associated mirnas and uses thereof IL179545A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/709,739 US7777022B2 (en) 2002-12-05 2004-05-26 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
US52245104P 2004-10-03 2004-10-03
US52245004P 2004-10-03 2004-10-03
US52245904P 2004-10-04 2004-10-04
US66509405P 2005-03-25 2005-03-25
PCT/IB2005/002352 WO2005116250A2 (en) 2004-05-26 2005-05-26 Viral and viral associated mirnas and uses thereof

Publications (2)

Publication Number Publication Date
IL179545A0 true IL179545A0 (en) 2007-05-15
IL179545A IL179545A (en) 2010-12-30

Family

ID=42331989

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179545A IL179545A (en) 2004-05-26 2006-11-23 Viral and viral associated mirnas and uses thereof

Country Status (7)

Country Link
EP (1) EP1751311A2 (en)
JP (1) JP2008500039A (en)
CN (1) CN101031658A (en)
AU (1) AU2005248149A1 (en)
CA (1) CA2567937A1 (en)
IL (1) IL179545A (en)
WO (1) WO2005116250A2 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219565A1 (en) 2002-10-21 2004-11-04 Sakari Kauppinen Oligonucleotides useful for detecting and analyzing nucleic acids of interest
US8071306B2 (en) 2005-01-25 2011-12-06 Merck Sharp & Dohme Corp. Methods for quantitating small RNA molecules
ATE480644T1 (en) * 2005-01-25 2010-09-15 Rosetta Inpharmatics Llc METHOD FOR QUANTIFYING SMALL RNA MOLECULES
AU2006254732A1 (en) * 2005-06-03 2006-12-07 Southern Adelaide Health Service-Flinders Medical Centre Targeting cells with altered microrna expression
WO2007113388A2 (en) * 2006-03-31 2007-10-11 Licentia Oy Method and microarray for detecting herpesviruses
US8007790B2 (en) 2006-04-03 2011-08-30 Stowers Institute For Medical Research Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
US7727725B2 (en) 2006-04-27 2010-06-01 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
JP2010500867A (en) * 2006-06-30 2010-01-14 ロゼッタ ジノミクス リミテッド Nucleic acid detection method
US8227590B2 (en) 2006-11-21 2012-07-24 Jawaharlal Nehru Centre For Advanced Scientific Research High sensitivity assay for molecular typing of biological sample, probes and a kit thereof
SG143090A1 (en) * 2006-11-27 2008-06-27 Agency Science Tech & Res Influenza b virus detection method and kit therefor
US8481506B2 (en) 2006-12-05 2013-07-09 Rosetta Genomics, Ltd. Nucleic acids involved in viral infection
EP2387616A2 (en) * 2009-01-16 2011-11-23 Cepheid Methods of detecting cervical cancer
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
US20140148348A1 (en) 2010-01-13 2014-05-29 Christine Kuslich Dectection of gastrointestinal disorders
AU2011205863B2 (en) * 2010-01-18 2014-08-28 Universiteit Utrecht Holding B.V. Means and methods for distinguishing FECV and FIPV
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (en) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 Circulating biomarkers for disease
KR101886457B1 (en) 2010-10-06 2018-08-07 큐알엔에이, 인크. Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
EP2756080B1 (en) 2011-09-14 2019-02-20 Translate Bio MA, Inc. Multimeric oligonucleotide compounds
US20130302784A1 (en) * 2012-03-30 2013-11-14 Intelligent Medical Devices, Inc. Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of herpes simplex virus
AU2013205110B2 (en) * 2012-04-24 2016-10-13 Gen-Probe Incorporated Compositions, Methods and Kits to Detect Herpes Simplex Virus Nucleic Acids
US11033620B2 (en) 2014-06-09 2021-06-15 Biomed Valley Discoveries, Inc. Combination therapies targeting tumor-associated stroma or tumor cells and microtubules
WO2015191617A2 (en) 2014-06-09 2015-12-17 Biomed Valley Discoveries, Inc. Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells
WO2015191610A2 (en) 2014-06-09 2015-12-17 Biomed Valley Discoveries, Inc. Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways
US10758614B2 (en) 2014-06-09 2020-09-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services National Institutes Of Health Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
US11034757B2 (en) 2014-06-09 2021-06-15 Biomed Valley Discoveries, Inc. Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature
US10434174B2 (en) 2014-06-09 2019-10-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
US10556020B2 (en) 2014-09-26 2020-02-11 University Of Massachusetts RNA-modulating agents
WO2016130943A1 (en) 2015-02-13 2016-08-18 Rana Therapeutics, Inc. Hybrid oligonucleotides and uses thereof
WO2017004079A1 (en) 2015-06-29 2017-01-05 Biomed Valley Discoveries, Inc. Lpt-723 and immune checkpoint inhibitor combinations and methods of treatment
WO2017134529A1 (en) * 2016-02-02 2017-08-10 Crispr Therapeutics Ag Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome
KR20190017872A (en) 2016-06-08 2019-02-20 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 A modified viral vector that reduces inflammation and induces immune responses
US11053496B2 (en) * 2016-06-14 2021-07-06 Agency For Science, Technology And Research Consequences of a defective switch in cutaneous squamous cell carcinoma
EP3661924A1 (en) 2017-07-31 2020-06-10 The Trustees of Columbia University in the City of New York Compounds, compositionals, and methods for treating t-cell acute lymphoblastic leukemia
KR20200085812A (en) 2017-11-08 2020-07-15 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Compositions and methods for inhibiting viral vector-induced inflammatory response
AU2019258585A1 (en) * 2018-04-23 2020-11-26 BiomeMega Pty Ltd A microbial sanitiser with broad applications
WO2019226832A1 (en) 2018-05-22 2019-11-28 Jie Shen Gene therapy for alzheimer's disease
US11866705B2 (en) 2018-07-31 2024-01-09 Osaka Univerity Small cell lung cancer therapeutic agent containing oligonucleotide
EP3853364A1 (en) * 2018-09-18 2021-07-28 Alnylam Pharmaceuticals, Inc. Ketohexokinase (khk) irna compositions and methods of use thereof
MX2022006499A (en) 2019-11-29 2022-08-15 Paros Bio Inc Gene therapy for neurodegenerative disorders.
AU2021213253A1 (en) * 2020-01-31 2022-09-08 Paros Bio, Inc. Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement
AU2022226098A1 (en) 2021-02-26 2023-08-24 Alnylam Pharmaceuticals, Inc. KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
JP7536187B2 (en) 2021-04-19 2024-08-19 ノヴォ ノルディスク アー／エス Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression - Patents.com
DE112022004237T5 (en) * 2021-09-03 2024-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein DNA aptamers and their use in the (pre-)diagnosis of cancer
US11898186B1 (en) 2022-08-10 2024-02-13 Genscript Usa Inc. Compositions and methods for preparing capped mRNA

Also Published As

Publication number Publication date
WO2005116250A8 (en) 2007-07-05
AU2005248149A1 (en) 2005-12-08
EP1751311A2 (en) 2007-02-14
JP2008500039A (en) 2008-01-10
WO2005116250A2 (en) 2005-12-08
CA2567937A1 (en) 2005-12-08
WO2005116250A3 (en) 2006-07-06
CN101031658A (en) 2007-09-05
IL179545A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
IL179545A (en) Viral and viral associated mirnas and uses thereof
IL212977A0 (en) Micrornas and uses thereof
IL182562A0 (en) Improved viral purification methods
AP2907A (en) Viral hepatitis treatment
EP1802588A4 (en) Substituted amino-pyrimidones and uses thereof
IL228770A0 (en) Processes and intermaediates
ZA200800256B (en) Antiviral compounds and methods
AP2008004576A0 (en) Novel viral factor
EP1781311A4 (en) Growth-hormone secretagogues
DE502005003298D1 (en) Ls
GB0416487D0 (en) Modified virus
IL179497A0 (en) Carboranylporphyrins and uses thereof
GB0417345D0 (en) Substituted organopolysiloxanes and uses thereof
PL2215908T3 (en) 2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
IL180365A0 (en) Carboranylporphyrins and uses thereof
GB2418628B (en) Improved laminates and the manufacture thereof
SG113564A1 (en) Releasing sheet
IL177759A0 (en) Cospeptin, cosmedin and their uses
GB0408424D0 (en) Viral assay
HU0401841D0 (en) Combined micropropagating process and bioreactor
GB0409596D0 (en) Novel herpes simplex viruses and uses thereof
GB0520800D0 (en) Viral treatment
IL165458A0 (en) And
GB0508060D0 (en) RNA viruses
GB0508061D0 (en) RNA viruses

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed